Caption Management’s Standard BioTools LAB Stock Holding History

Caption Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$38.6K	–	1664
2024 Q3	$38.6K	Hold	20,000	–	–	﹤0.01%	1180
2024 Q2	$35.4K	Buy	+20,000	New	+$48.9K	﹤0.01%	1074
2021 Q2	–	Sell	-160,000	Closed	-$724K	–	1452
2021 Q1	$724K	Buy	160,000 +97,000	+154%	+$533K	0.02%	738
2020 Q4	$378K	Buy	+63,000	New	+$414K	0.01%	777

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Caption Management's LAB Position: Q4 2024 in Review

Caption Management sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 8,000 shares — an estimated $15.4K sold.

Caption Management first reported a position in LAB in Q4 2020 and held it in 5 quarters. The position peaked at $562K in Q1 2021. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

Caption Management reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
Caption Management sold 8,000 Standard BioTools shares in Q4 2024, an estimated $15.4K.
Caption Management first reported a position in Standard BioTools in Q4 2020 and held it in 5 quarters.
Caption Management's Standard BioTools position peaked at $562K in Q1 2021.
142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.